Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 198
Filtrar
1.
Indian J Ophthalmol ; 72(Suppl 4): S601-S605, 2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38324620

RESUMEN

PURPOSE: To study the role of Toxoplasma IgG avidity in evaluating the stage of systemic infection during manifestation as toxoplasma retinochoroiditis and its clinical implications in eastern India. METHODS: Retrospective chart review of Toxoplasma retinochoroiditis cases with Toxoplasma serology for IgG, IgM, and IgG avidity. RESULTS: Included in this study were 17 eyes of 17 patients who had active retinitis located in the macula (14), mid-periphery (2), or periphery (1). They were either primary lesions (12) or reactivations (5). All the cases had Toxoplasma IgG positive; one case had IgM positivity, while all the cases had high IgG avidity values. IgG avidity had a positive correlation with the duration of symptoms. CONCLUSION: We observed high IgG avidity values in active retinochoroiditis in both primary ocular Toxoplasmosis and reactivation subgroups. These results indicate a late ocular manifestation after initial systemic infection with a possible incubation period ranging from 5 weeks to 5 months.


Asunto(s)
Anticuerpos Antiprotozoarios , Coriorretinitis , Inmunoglobulina G , Toxoplasma , Toxoplasmosis Ocular , Humanos , Toxoplasmosis Ocular/inmunología , Toxoplasmosis Ocular/diagnóstico , Toxoplasmosis Ocular/parasitología , Estudios Retrospectivos , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Femenino , Masculino , Toxoplasma/inmunología , Coriorretinitis/parasitología , Coriorretinitis/inmunología , Coriorretinitis/diagnóstico , Adulto , Anticuerpos Antiprotozoarios/sangre , Anticuerpos Antiprotozoarios/inmunología , Adulto Joven , Adolescente , Niño , Infecciones Parasitarias del Ojo/parasitología , Infecciones Parasitarias del Ojo/diagnóstico , Infecciones Parasitarias del Ojo/inmunología , Inmunoglobulina M/sangre , Inmunoglobulina M/inmunología , Persona de Mediana Edad , Afinidad de Anticuerpos , Estudios de Seguimiento
2.
Sci Rep ; 12(1): 1156, 2022 01 21.
Artículo en Inglés | MEDLINE | ID: mdl-35064148

RESUMEN

Toxoplasmic retinochoroiditis is a common, potentially blinding parasitic infection. We sought to define the spectrum and frequency of signs of active toxoplasmic retinochoroiditis by spectral domain optical coherence tomography (SD-OCT), and to identify clinical associations. Ninety eyes of 90 individuals presenting consecutively to a tertiary referral uveitis service with active toxoplasmic retinochoroiditis and gradable SD-OCT scans were evaluated prospectively. SD-OCT features were collated, and associations with lesion location, primary versus recurrent episode, serological status, human immunodeficiency virus infection and best-corrected Snellen visual acuity were explored. Active toxoplasmic retinochoroiditis presented with thickened (65%) and hyperreflective (61%) retina, choroidal thickening (55%) and hyporeflectivity (61%), hyperreflective vitreous dots (80%) and deposits (36%), and posterior hyaloid thickening (35%) on SD-OCT. Most signs occurred with similar frequency across clinical groups. Retinal hyporeflectivity (17%) was significantly associated with a visual acuity of 20/200 or worse at resolution. Our observations demonstrate that active toxoplasmic retinochoroiditis has diverse SD-OCT signs and that none are universally present. Retinal hyporeflectivity-suggesting liquefactive necrosis-predicts poor visual outcome.


Asunto(s)
Coriorretinitis/diagnóstico , Segmento Posterior del Ojo/diagnóstico por imagen , Tomografía de Coherencia Óptica , Toxoplasmosis Ocular/diagnóstico , Adolescente , Adulto , Antiinfecciosos/uso terapéutico , Coriorretinitis/inmunología , Coriorretinitis/parasitología , Quimioterapia Combinada/métodos , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Segmento Posterior del Ojo/inmunología , Toxoplasma/inmunología , Toxoplasma/aislamiento & purificación , Toxoplasmosis Ocular/complicaciones , Toxoplasmosis Ocular/tratamiento farmacológico , Toxoplasmosis Ocular/inmunología , Agudeza Visual , Adulto Joven
3.
Retin Cases Brief Rep ; 15(3): 243-245, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-30015769

RESUMEN

PURPOSE: We report a case of congenital toxoplasmosis associated with retinal detachment. METHODS: A 9-month-old white boy presented a unilateral tractional retina detachment associated with congenital toxoplasmosis retinochoroiditis. RESULTS: The diagnosis is supported by positive IgG (>400) for toxoplasmosis and intracranial calcification on magnetic resonance imaging, along with positive family history of Toxoplasma infection in the mother. CONCLUSION: Tractional retinal detachment is an infrequent and unconventional presentation of congenital Toxoplasma infection. Inflammatory interference with normal sequence of vitreous development may explain pathogenesis of tractional retinal detachments in the setting of congenital ocular toxoplasmosis.


Asunto(s)
Coriorretinitis/diagnóstico , Infecciones Parasitarias del Ojo/diagnóstico , Desprendimiento de Retina/diagnóstico , Toxoplasmosis Congénita/diagnóstico , Toxoplasmosis Ocular/diagnóstico , Anticuerpos Antiprotozoarios/sangre , Coriorretinitis/inmunología , Humanos , Inmunoglobulina G/sangre , Lactante , Masculino , Desprendimiento de Retina/inmunología , Toxoplasma/inmunología , Toxoplasmosis Congénita/inmunología , Toxoplasmosis Ocular/inmunología
5.
Ocul Immunol Inflamm ; 27(6): 949-957, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30081671

RESUMEN

Purpose: The purpose of this article is to analyze possible associations between systemic and ocular cytokine levels and specific clinical ophthalmologic signs from patients with a reactivation of toxoplasmic retinochoroiditis (RTR). Methods: A total of 18 patients with an active RTR episode, 8 patients with inactive scars, and 14 control patients were included in the study. Serum samples and aqueous humor (AH) samples were analyzed for IFN (interferon)-γ, interleukin (IL)-10, and IL-6 levels by ELISA. Inflammation grade, location, and size of the retinochoroidal active lesion, sampling time, and time to resolution were recorded. Results: A significantly negative correlation between AH and serum levels of IFN-γ was detected (p < 0.05). Patients with an AH IFN-γ/IL-10 ratio lower than 1 were associated with the longest time to resolution and/or severe complications. Conclusion: Serum IFN-γ levels may be used as a prognostic marker for both time to resolution and the development of possible severe complications during a given RTR episode.


Asunto(s)
Biomarcadores/sangre , Coriorretinitis/parasitología , Interferón gamma/sangre , Interleucina-10/sangre , Interleucina-6/sangre , Toxoplasma/fisiología , Toxoplasmosis Ocular/parasitología , Adulto , Antiprotozoarios/uso terapéutico , Humor Acuoso/metabolismo , Coriorretinitis/tratamiento farmacológico , Coriorretinitis/inmunología , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Factores Inmunológicos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Toxoplasmosis Ocular/tratamiento farmacológico , Toxoplasmosis Ocular/inmunología , Adulto Joven
6.
Am J Ophthalmol ; 199: 82-93, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30502335

RESUMEN

PURPOSE: To investigate clinical and biological factors influencing recurrences of severe toxoplasmic retinochoroiditis (TRC) confirmed by aqueous humor analysis. DESIGN: Retrospective case series. METHODS: Retrospective analysis of 87 subjects with severe TRC, proven by positive Goldmann-Witmer coefficient (GWC), Toxoplasma gondii (T. gondii) immunoblot, or T. gondii-specific polymerase chain reaction (PCR) in aqueous humor. Cases with immunosuppression or retinal scars without previous recorded episode were excluded. Time-dependent, clinical, treatment-related, and biological factors were explored by univariate and multivariate shared frailty survival analyses. RESULTS: Among 44 included subjects (age, 40.4 ± 17.6 years; follow-up, 8.3 ± 2.7 years), 22 presented recurrences. There was 0.11 recurrence/patient/year and mean disease-free interval was 5.0 ± 2.9 years. The risk of recurrence was higher immediately after an episode (P < .0001). Among recurrent cases, the risk of multiple recurrences was higher when the first recurrence occurred after longer disease-free intervals (P = .046). In univariate analysis, the recurrence risk declined with higher number of intense bands on aqueous T. gondii immunoblot (P = .006), and increased when venous vasculitis was present initially (P = .019). Multivariate analysis confirmed that eyes with more intense bands on immunoblot had fewer recurrences (P = .041). There was a near-significant risk elevation after pyrimethamine/azithromycin treatment (P = .078 and P = .054, univariate and multivariate). Intravenous corticosteroid administration, oral corticosteroid administration, aqueous GWC, and T. gondii PCR did not influence recurrences (P = .12, P = .10, P = .39, and P = .96, respectively). CONCLUSIONS: Recurrences of severe TRC are not random and may be influenced by clinical and biological factors possibly related to blood-retinal barrier alterations. These results may contribute to identifying biomarkers for TRC reactivation.


Asunto(s)
Humor Acuoso/parasitología , Coriorretinitis/diagnóstico , Infecciones Parasitarias del Ojo/diagnóstico , Toxoplasmosis Ocular/diagnóstico , Administración Oral , Adolescente , Adulto , Anciano , Anticuerpos Antiprotozoarios/inmunología , Factores Biológicos , Coriorretinitis/genética , Coriorretinitis/inmunología , Coriorretinitis/parasitología , ADN Protozoario/genética , Infecciones Parasitarias del Ojo/genética , Infecciones Parasitarias del Ojo/inmunología , Infecciones Parasitarias del Ojo/parasitología , Femenino , Estudios de Seguimiento , Glucocorticoides/administración & dosificación , Humanos , Immunoblotting , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Recurrencia , Estudios Retrospectivos , Toxoplasma/genética , Toxoplasma/inmunología , Toxoplasmosis Ocular/genética , Toxoplasmosis Ocular/inmunología , Toxoplasmosis Ocular/parasitología
7.
Front Immunol ; 9: 2463, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30425713

RESUMEN

Four inflammatory diseases are strongly associated with Major Histocompatibility Complex class I (MHC-I) molecules: birdshot chorioretinopathy (HLA-A*29:02), ankylosing spondylitis (HLA-B*27), Behçet's disease (HLA-B*51), and psoriasis (HLA-C*06:02). The endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 are also risk factors for these diseases. Since both enzymes are involved in the final processing steps of MHC-I ligands it is reasonable to assume that MHC-I-bound peptides play a significant pathogenetic role. This review will mainly focus on recent studies concerning the effects of ERAP1 and ERAP2 polymorphism and expression on shaping the peptidome of disease-associated MHC-I molecules in live cells. These studies will be discussed in the context of the distinct mechanisms and substrate preferences of both enzymes, their different patterns of genetic association with various diseases, the role of polymorphisms determining changes in enzymatic activity or expression levels, and the distinct peptidomes of disease-associated MHC-I allotypes. ERAP1 and ERAP2 polymorphism and expression induce significant changes in multiple MHC-I-bound peptidomes. These changes are MHC allotype-specific and, without excluding a degree of functional inter-dependence between both enzymes, reflect largely separate roles in their processing of MHC-I ligands. The studies reviewed here provide a molecular basis for the distinct patterns of genetic association of ERAP1 and ERAP2 with disease and for the pathogenetic role of peptides. The allotype-dependent alterations induced on distinct peptidomes may explain that the joint association of both enzymes and unrelated MHC-I alleles influence different pathological outcomes.


Asunto(s)
Aminopeptidasas/genética , Síndrome de Behçet/genética , Coriorretinitis/genética , Antígenos de Histocompatibilidad Clase I/genética , Antígenos de Histocompatibilidad Menor/genética , Psoriasis/genética , Espondilitis Anquilosante/genética , Síndrome de Behçet/inmunología , Retinocoroidopatía en Perdigonada , Coriorretinitis/inmunología , Genes MHC Clase I/genética , Predisposición Genética a la Enfermedad/genética , Antígenos de Histocompatibilidad Clase I/inmunología , Humanos , Polimorfismo de Nucleótido Simple/genética , Psoriasis/inmunología , Espondilitis Anquilosante/inmunología
8.
Indian J Ophthalmol ; 65(10): 1043-1046, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29044084

RESUMEN

A 44-year-old male presented with a history of defective vision in the right eye for the past 5 months with the previous history of tubercular cervical lymphadenitis. On examination, right eye revealed panuveitis with dense vitritis and chorioretinitis in the superotemporal quadrant. His Mantoux test was positive (25 mm × 25 mm induration), QuantiFERON-TB Gold was test positive, aqueous aspirate was positive for Mycobacterium tuberculosis genome, negative for viruses and toxoplasma, and hence he was initiated on four-drug antitubercular therapy (ATT) with oral steroids. On follow-up, he had worsening of vitritis and intravenous methylprednisolone was given suspecting paradoxical reaction to ATT; however, a repeat AC tap was positive for toxoplasma B1 genome, IgG antitoxoplasma antibody was also positive in serum and aqueous; hence, we switched to systemic antitoxoplasma therapy. He underwent a therapeutic vitrectomy along with intravitreal clindamycin and dexamethasone for persistent vitreous membranes and vitritis. The patient responded well to the treatment with a reduction in vitritis and scarring of the lesion.


Asunto(s)
Coriorretinitis/diagnóstico , ADN Bacteriano/análisis , Huésped Inmunocomprometido , Mycobacterium tuberculosis/genética , Tuberculosis Ocular/diagnóstico , Adulto , Coriorretinitis/inmunología , Coriorretinitis/microbiología , Diagnóstico Diferencial , Electrorretinografía , Humanos , Masculino , Reacción en Cadena en Tiempo Real de la Polimerasa , Tuberculosis Ocular/inmunología , Tuberculosis Ocular/microbiología , Agudeza Visual
9.
Ocul Immunol Inflamm ; 25(5): 610-620, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28362542

RESUMEN

PURPOSE: Adaptive optics scanning laser ophthalmoscopy (AOSLO) allows en face visualization of specific layers of the retina. This pilot study evaluated the ability of AOSLO to visualize photoreceptor integrity in patients with birdshot chorioretinopathy (BCR). METHOD: A total of 16 consecutive patients with HLA-A29+ BCR were imaged using the prototype Apaeros retinal imaging system. Images of high quality were aligned with infrared reflectance photos and correlated with spectral domain optical coherence tomography (SD-OCT). RESULTS: Images of four eyes of three patients were of sufficient quality to allow posterior pole montage and point-to-point correlation with SD-OCT. Areas of photoreceptor disruption on SD-OCT were seen as patchy areas of loss on AOSLO, whereas areas of intact interdigitation zone and inner segment/outer segment junction correlated with normal appearing photoreceptors on AOSLO. CONCLUSIONS: Using AOSLO, we found one instance of subclinical photoreceptor disruption not seen on SD-OCT. Ultimately, there are unique challenges associated with imaging BCR patients using AOSLO.


Asunto(s)
Coriorretinitis/diagnóstico por imagen , Diagnóstico por Imagen/instrumentación , Oftalmoscopía/métodos , Células Fotorreceptoras Retinianas Conos/patología , Adulto , Retinocoroidopatía en Perdigonada , Coriorretinitis/inmunología , Femenino , Antígenos HLA-A/inmunología , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Estudios Prospectivos , Tomografía de Coherencia Óptica , Agudeza Visual/fisiología
12.
Mol Immunol ; 77: 193-204, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27522479

RESUMEN

The inflammatory diseases that are most strongly associated with major histocompatibility Complex class I (MHC-I) alleles are also influenced by endoplasmic reticulum aminopeptidase (ERAP) 1 and/or 2, often in epistasis with the susceptibility MHC-I allele. This review will focus on the four major MHC-I-associated inflammatory disorders: ankylosing spondylitis, birdshot chorioretinopathy, Behçet's disease and psoriasis. The genetics of ERAP1/ERAP2 association and the alterations induced by polymorphism of these enzymes on the risk MHC-I allotypes will be examined. A pattern emerges of analogous effects on peptide length, sequence and affinity of disparate peptidomes, suggesting that similar peptide-mediated mechanisms underlie the pathogenesis and the joint contribution of ERAP1/ERAP2 and MHC-I to distinct inflammatory diseases. Processing of specific antigens, peptide-dependent changes in global properties of the MHC-I molecules, such as folding and stability, or both may be pathogenic.


Asunto(s)
Aminopeptidasas/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Inflamación/inmunología , Antígenos de Histocompatibilidad Menor/inmunología , Aminopeptidasas/genética , Animales , Síndrome de Behçet/genética , Síndrome de Behçet/inmunología , Retinocoroidopatía en Perdigonada , Coriorretinitis/genética , Coriorretinitis/inmunología , Predisposición Genética a la Enfermedad , Humanos , Inflamación/genética , Antígenos de Histocompatibilidad Menor/genética , Polimorfismo de Nucleótido Simple , Psoriasis/genética , Psoriasis/inmunología , Espondilitis Anquilosante/genética , Espondilitis Anquilosante/inmunología
13.
Am J Ophthalmol ; 170: 190-196, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27523490

RESUMEN

PURPOSE: To determine the prognostic factors of long-term visual outcome in birdshot retinochoroidopathy (BRC). METHODS: Design: Retrospective case series. Study Population: Successive HLA-A29+ BRC patients whose latest visit was between May and August 2013 at a single tertiary center (Pitié-Salpétrière Hospital, Paris). OBSERVATION PROCEDURE: Endpoint visual status (remission or deterioration) was determined for each patient based on clinical and ancillary data from the latest visit including optical coherence tomography (OCT), automated visual field (AVF), and angiograms. Main Outcome Measure: Epidemiologic, clinical, OCT, AVF, angiographic, and electrophysiological data at baseline were correlated to final visual status. RESULTS: Fifty-five patients were included. Mean observation period was 8 years (range: 0.6-23 years). Mean disease duration was 9.8 years (range: 1.2-32.7 years). Female-to-male sex ratio was 1.6:1. Factors of good visual prognosis (remission vs deterioration) included at baseline: late age of disease onset (49.5 vs 45 years, P = .05), presence of vitreous inflammatory reactions >2+ (35.9% vs 6.2%, P = .04), vascular leakage on fluorescein angiograms (FA) (44.4% vs 12.5%, P = .03), absence of macular pigment epithelium atrophy on FA (88.9% vs 62.5%, P = .05), and presence of macular edema on OCT (33.3% vs 6.2%, P = .04). Preserved electrooculography light peak and Arden ratio (P = .06) and presence of choroidal spots on infracyanine green angiograms (80.0% vs 53.3%, P = .08) seemed associated with the best prognoses. CONCLUSION: This study suggests a series of prognostic factors of long-term visual outcome in BRC. Keeping in mind the insidious evolution of the disease, knowledge of such prognostic factors should help tailor the treatment and monitoring of birdshot patients.


Asunto(s)
Coriorretinitis/diagnóstico , Trastornos de la Visión/diagnóstico , Agudeza Visual/fisiología , Campos Visuales/fisiología , Adulto , Anciano , Retinocoroidopatía en Perdigonada , Permeabilidad Capilar , Coriorretinitis/tratamiento farmacológico , Coriorretinitis/inmunología , Coriorretinitis/fisiopatología , Electrooculografía , Oftalmopatías/diagnóstico , Femenino , Angiografía con Fluoresceína , Estudios de Seguimiento , Glucocorticoides/uso terapéutico , Antígenos HLA-A/inmunología , Humanos , Edema Macular/diagnóstico , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Tomografía de Coherencia Óptica , Trastornos de la Visión/fisiopatología , Cuerpo Vítreo/patología
14.
Med Hypotheses ; 90: 48-50, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27063084

RESUMEN

In-vitro immunofluorescent assays/imaging are routinely used methods of detecting antigens. The ability to perform ocular angiography to study the choroidal and retinal vasculature in real time provides us with a unique opportunity to perform real time in-vivo immunofluorescent imaging. This unique combination of in-vivo immunofluorescent imaging and live imaging of choroidal and retinal circulation can help detect antigens of infective organisms in-vivo to diagnose causative infective aetiology in cases of choroiditis/retinitis. The following paper describes the basic designing of such an imaging platform.


Asunto(s)
Coroides/irrigación sanguínea , Angiografía con Fluoresceína/métodos , Técnica del Anticuerpo Fluorescente Directa/métodos , Vasos Retinianos/diagnóstico por imagen , Uveítis Posterior/diagnóstico por imagen , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacocinética , Reacciones Antígeno-Anticuerpo , Antígenos Bacterianos/análisis , Antígenos Bacterianos/inmunología , Antígenos Fúngicos/análisis , Antígenos Fúngicos/inmunología , Barrera Hematorretinal , Coriorretinitis/diagnóstico por imagen , Coriorretinitis/inmunología , Coriorretinitis/microbiología , Coroides/diagnóstico por imagen , Colorantes Fluorescentes/farmacocinética , Fondo de Ojo , Humanos , Fragmentos Fab de Inmunoglobulinas/inmunología , Fragmentos Fc de Inmunoglobulinas/inmunología , Verde de Indocianina/farmacocinética , Proteínas Recombinantes/inmunología , Proteínas Recombinantes/farmacocinética , Uveítis Posterior/inmunología
15.
J Infect Dis ; 213(12): 1962-70, 2016 06 15.
Artículo en Inglés | MEDLINE | ID: mdl-26946460

RESUMEN

BACKGROUND: Ocular toxoplasmosis is a prominent and severe condition of high incidence in Brazil. The current study provides new insights into the immunological events that can be associated with retinochoroiditis in the setting of congenital toxoplasmosis in human infants. METHODS: Flow cytometry of intracytoplasmic cytokines in leukocyte subsets following in vitro short-term antigenic recall in infants with congenital T. gondii infection. RESULTS: Our data demonstrates that whereas neutrophils and monocytes from T. gondii-infected infants display a combination of proinflammatory and regulatory cytokine profiles, natural killer cells showed a predominantly proinflammatory profile upon in vitro T. gondii stimulation. The proinflammatory response of CD4(+) and CD8(+) T cells, characterized by the production of interferon γ (IFN-γ) and interleukin 17 in patients with an active retinochoroidal lesion, revealed the presence of IFN-γ and tumor necrosis factor α during early and late immunological events. This specific proinflammatory pattern is associated with early events and active retinochoroidal lesion, whereas a robust monocyte-derived interleukin 10-mediated profile is observed in children with cicatricial ocular lesions. CONCLUSIONS: These findings support the existence of a progressive immunological environment concomitant with the initial, apical, and cicatricial phases in the process of retinochoroidal lesion formation in infants with congenital toxoplasmosis that may be relevant in the establishment of stage-specific clinical management.


Asunto(s)
Coriorretinitis/inmunología , Citocinas/inmunología , Toxoplasma/inmunología , Toxoplasmosis Ocular/inmunología , Brasil , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Coriorretinitis/congénito , Coriorretinitis/parasitología , Humanos , Lactante , Células Asesinas Naturales/inmunología , Masculino , Monocitos/inmunología , Neutrófilos/inmunología , Toxoplasmosis Ocular/congénito , Toxoplasmosis Ocular/parasitología
18.
Ocul Immunol Inflamm ; 24(1): 110-2, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-25010254

RESUMEN

PURPOSE: To report the first documented case of HLA-A29(+) birdshot chorioretinopathy in a Hispanic patient. CASE DESCRIPTION: A 62-year-old female from Mexico presented with a 15-year history of progressive nyctalopia, floaters, and decreasing vision. She carried multiple previous diagnoses, including posterior vitreous detachment and macular edema. Both fundi showed characteristic creamy ill-defined lesions of birdshot chorioretinopathy, mostly atrophic, with evidence of old periphlebitis and arteriolar attenuation. Bilateral macular atrophy resulted in compromised visual acuity. Workup revealed positive HLA-A29 and was negative for TB and syphilis. CONCLUSION: Despite having been reported almost exclusively in non-Hispanic Caucasians, HLA-A29-positive birdshot chorioretinopathy may occur in Hispanic patients. This patient's ethnicity may have resulted in a significant delay in diagnosis.


Asunto(s)
Coriorretinitis/diagnóstico , Antígenos HLA-A/inmunología , Americanos Mexicanos/etnología , Retinocoroidopatía en Perdigonada , Coriorretinitis/etnología , Coriorretinitis/inmunología , Electrorretinografía , Femenino , Angiografía con Fluoresceína , Humanos , Persona de Mediana Edad , Tomografía de Coherencia Óptica , Agudeza Visual/fisiología
19.
JAMA Ophthalmol ; 133(7): 840-3, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25906054

RESUMEN

IMPORTANCE: To describe a cohort of patients with birdshot chorioretinopathy who did not manifest birdshot lesions on clinical examination but had retinal vasculitis, low-grade to moderate vitritis, and hypocyanescent lesions on indocyanine green angiography (ICGA). OBSERVATIONS: Case series of 3 patients with mild to moderate vitritis and retinal vasculitis without definite birdshot lesions on clinical examination evaluated from January 2007 to December 2014 at 4 academic ophthalmology centers. All patients' results were positive for human leukocyte antigen-A29. All cases had hypocyanescent lesions visible on ICGA but not detectable on fluorescein angiography. CONCLUSIONS AND RELEVANCE: Patients with retinal vasculitis and low-grade vitritis with or without macular edema may have birdshot chorioretinopathy evident on ICGA before lesions are visible on clinical examination or fluorescein angiography. Expanding birdshot chorioretinopathy diagnostic criteria to include the presence of hypocyanescent lesions on ICGA could improve the sensitivity of diagnosis.


Asunto(s)
Angiografía/métodos , Coriorretinitis/diagnóstico por imagen , Coriorretinitis/tratamiento farmacológico , Antígenos HLA-A/análisis , Verde de Indocianina , Corticoesteroides/uso terapéutico , Adulto , Retinocoroidopatía en Perdigonada , Coriorretinitis/inmunología , Femenino , Angiografía con Fluoresceína/métodos , Estudios de Seguimiento , Antígenos HLA-A/inmunología , Humanos , Masculino , Persona de Mediana Edad , Imagen Óptica/métodos , Estudios Retrospectivos , Muestreo , Sensibilidad y Especificidad , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
20.
Arq Bras Oftalmol ; 78(1): 56-61, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25714542

RESUMEN

Birdshot retinochoroidopathy (BSRC) is a distinct type of posterior uveitis originally described in the 1940s. Its characteristics include minimal anterior segment inflammation and diffuse posterior choroidopathy with vitritis and retinal vasculitis. The precise etiology of this disease is yet to be elucidated. However, various treatment modalities have been employed with the ultimate goal of durable remission of this vision threatening intraocular disease. The purpose of this review is not only to emphasize the importance of recognizing BSRC, but also to discuss the new discoveries, immune mediators, current and new therapies, and techniques applied to monitor and accomplish disease remission.


Asunto(s)
Coriorretinitis , Enfermedades de la Coroides , Enfermedades de la Retina , Anticuerpos Monoclonales Humanizados/uso terapéutico , Coriorretinitis/diagnóstico , Coriorretinitis/tratamiento farmacológico , Coriorretinitis/inmunología , Enfermedades de la Coroides/diagnóstico , Enfermedades de la Coroides/tratamiento farmacológico , Enfermedades de la Coroides/inmunología , Diagnóstico Diferencial , Quimioterapia Combinada , Electrorretinografía , Angiografía con Fluoresceína , Antígenos HLA-A/inmunología , Humanos , Inmunosupresores/uso terapéutico , Inducción de Remisión , Enfermedades de la Retina/diagnóstico , Enfermedades de la Retina/tratamiento farmacológico , Enfermedades de la Retina/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...